Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy

Statistics in Medicine

Volumn 31, Issue 17, 2012, Pages 1887-1902

  Almirall, Daniel ^a   Compton, Scott N ^b   Gunlicks Stoessel, Meredith ^c   Duan, Naihua ^d   Murphy, Susan A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Adaptive; Dynamic treatment regimes; Experimental; Individualized; Intervention; Pilot

Indexed keywords

ADAPTIVE TREATMENT STRATEGY; ARTICLE; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL RESEARCH; COGNITIVE THERAPY; FEASIBILITY STUDY; HEALTH SERVICE; METHODOLOGY; PILOT STUDY; PRACTICE GUIDELINE; PROCESS DESIGN; PROCESS OPTIMIZATION; RANDOMIZATION; SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMIZED TRIAL; TREATMENT PLANNING;

ANXIETY DISORDERS; CHILD; COGNITIVE THERAPY; HUMANS; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SERTRALINE;

EID: 84864002341     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4512     Document Type: Article

References (45)

1. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Archives of General Psychiatry Feb 2009; 66(2):128-133.
2. Birmaher B. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry Nov 2007; 46(11):1503-1526.
3. Connolly SD, Bernstein GA, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry Feb 2007; 46(2):267-283.
4. Murphy SA, Lynch KG, Oslin D, Mckay JR, TenHave T. Developing adaptive treatment strategies in substance abuse. Drug and Alcohol Dependence May 2007; 88:S24-S30.
5. Murphy SA, Collins LM, Rush AJ. Customizing treatment to the patient: Adaptive treatment strategies. Drug and Alcohol Dependence May 2007; 88:S1-S3.
6. Dawson R, Lavori PW. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies. Statistics in Medicine Nov 2004; 23(21):3249-3262.
7. Lavori PW, Dawson R, Rush AJ. Flexible treatment strategies in chronic disease: clinical and research implications. Biological Psychiatry Sep 2000; 48(6):605-614.
8. Murphy SA, Almirall D. Dynamic Treatment Regimens. In Encyclopedia of Medical Decision Making, Kattan MW (ed.). Sage Publications: Thousand Oaks, CA, 2009.
9. Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clinical Trials Feb 2004; 1(1):9-20.
10. Murphy SA. Optimal dynamic treatment regimes. Journal of the Royal Statistical Society Series B 2003; 65:331-355.
11. Hernán MA, Lanoy E, Costagliola D, Robins JM. Comparison of Dynamic Treatment Regimes via Inverse Probability Weighting. Basic & Clinical Pharmacology & Toxicology 2006; 98:237-242.
12. Moodie EEM, Richardson TS, Stephens DA. Demystifying optimal dynamic treatment regimes. Biometrics 2007; 63:447-455.
13. Murphy SA, van der Laan MJ, Robins JM, CPPRG. Marginal Mean Models for Dynamic Regimes. Journal of the American Statistical Association 2001; 96:1410-1423.
14. Orellana L, Rotnitzky A, Robins JM. Dynamic Regime Marginal Structural Mean Models for Estimation of Optimal Dynamic Treatment Regimes, Part I: Main Content. The International Journal of Biostatistics 2010; 6(2). Article No. 8.
15. Orellana L, Rotnitzky A, Robins JM. Dynamic Regime Marginal Structural Mean Models for Estimation of Optimal Dynamic Treatment Regimes, Part II: Proofs of Results. The International Journal of Biostatistics 2010; 6(2). Article No. 9.
16. Robins JM. Optimal structural nested models for optimal sequential decisions. In Proceedings of the Second Seattle Symposium on Biostatistics, Lin DY, Heagerty PJ (eds.). Springer: New York, 2004.
17. van der Laan MJ, Petersen ML, Joffe MM. History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimes. The International Journal of Biostatistics 2005; 1(1). Article No. 4.
18. Wahed AS, Tsiatis AA. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics 2004; 60:124-133.
19. Bembon O, van der Laan MJ. Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules. Statistics in Medicine Aug 2008; 27(19):3689-3716.
20. Cain LE, Robins JM, Lanoy E, Logan R, Costagliola D, Hernán MA. When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data. The International Journal of Biostatistics 2010; 6(2). Article No. 18.
21. Murphy SA, Bingham D. Screening Experiments for Developing Dynamic Treatment Regimes. Journal of the American Statistical Association 2009; 184:391-408.
22. Thall PF, Millikan RE, Sung HG. Evaluating multiple treatment courses in clinical trials. Statistics in Medicine Apr 2000; 19(8):1011-1028.
23. Murphy SA. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine May 2005; 24(10):1455-1481.
24. Lavori PW, Dawson R. Improving the efficiency of estimation in randomized trials of adaptive treatment strategies. Clinical Trials 2007; 4(4):297-308.
25. Lavori PW, Dawson R. Adaptive treatment strategies in chronic disease. Annual Review of Medicine 2008; 59:443-453.
26. Institute of Medicine. 100 Initial Priority Topics for Comparative Effectiveness Research.
27. Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. American Journalof Geriatric Psychiatry Fall 2001; 9(4):346-360.
28. Lavori PW, Rush AJ, Wisniewski SR, et al. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biological Psychiatry Nov 2001; 50(10):792-801.
29. Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte BP, Shon SP, Rago WV, Altshuler KZ, TMAP Research Group. Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. Journal ofClinical Psychiatry Apr 2003; 64(4):357-369.
30. Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. New England Journal of Medicine Jun 1995; 332(25):1671-1677.
31. Vogt WP. Dictionary of statistics and methodology: a nontechnical guide for the social sciences. Sage Publications: Newbury Park, California, 1993.
32. Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Annals of Behavioral Medicine Aug 2005; 30(1):65-73.
33. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Archives of General Psychiatry May 2006; 63(5):484-489.
34. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology Jan 2010; 10(1).
35. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. Journal of Evaluation in Clinical Practice May 2004; 10(2):307-312.
36. Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. Journal of Psychiatric Research May 2011; 45(5):626-629.
37. Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Statistics in Medicine 1990; 9:65-72.
38. Wittes JT, Schabenberger O, Zucker DM, Brittain E, Proschan M. Internal pilot studies I: type I error rate of the naïve t-test. Statistics in Medicine 1999; 18:3481-3491.
39. Zucker DM, Wittes JT, Schabenberger O, Brittain E. Internal pilot studies II: comparison of various procedures. Statistics in Medicine 1999; 18:3493-3509.
40. Nahum-Shani I, Qian M, Almirall D, Pelham WE, Gnagy B, Fabiano G, Waxmonsky J, Yu J, Murphy SA. Q-Learning: a data analysis method for constructing adaptive interventions. Pennsylvania State University Methodology Center Technical Report Series. No. 10-107.
41. Berry SM, Carlin BP, Lee JJ, Muller P. Bayesian adaptive methods for clinical trials. CRC Press: Boca Raton, FL, 2011.
42. The Methodology Center Perspective. Ask a Methodologist Spring 2011; Methodology Center, Pennsylvania State University.
43. Guy W. ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health: Rockville, MD, 1976.
44. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry Jun 2001; 158(6):848-856.
45. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria.